As diabetes care continues to be a major focus, innovative treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy advancement in GLP-1 receptor agonist medications. While https://bookmarkzap.com/story22026367/retatrutid-vs-tirzepatide-vs-semaglutide-a-direct-comparison